.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

AR-V7 Testing in Prostate Cancer

EP. 1: The Biology of Prostate Cancer

July 31st 2017

EP. 2: Prostate Cancer: Discovery and Importance of AR-V7

July 31st 2017

EP. 3: AR-V7 as a Predictive Marker in Prostate Cancer

July 31st 2017

EP. 4: Detection of AR-V7 in Prostate Cancer

July 31st 2017

EP. 5: Prostate Cancer: Epic Sciences AR-V7 Test

July 31st 2017

EP. 6: John's Hopkins AR-V7 Test in Prostate

July 31st 2017

EP. 7: Prostate Cancer: Validation of AR-V7 Testing

July 31st 2017

EP. 8: Practical Implications of AR-V7 Testing in Prostate

July 31st 2017

EP. 9: Prostate Cancer: Educating Physicians About AR-V7 Testing

July 31st 2017

EP. 10: Recent AR-V7 Data in Prostate Cancer

July 31st 2017